Cimzia 2X200 MG/ML syringe kits
Ended Awarded
- Contract number
- SPE2DB25FZ1CN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,122
Award facts
- Contract value 100% obligated
- $14,122.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,122.12 to AmerisourceBergen Drug Corp for the supply of CIMZIA 2x200 mg/mL syringe kits. The award, issued on September 17, 2025, with an ultimate completion date of October 8, 2025, represents a firm fixed-price contract with no set-aside designation. Performance will be executed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a critical federal medical procurement vendor through competitive awards with the Defense Logistics Agency. The company's federal contract portfolio demonstrates extensive capability in supplying specialty medications, brand-name and generic pharmaceuticals, vaccines, and specialized medical supplies across multiple therapeutic domains. The DLA's Medical Supply Chain relies on AmerisourceBergen to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company is positioned as a key vendor within the broader DLA Pharmaceutical Prime Vendor Global Program framework, which is planning multiple regional awards to support U.S. military and veteran healthcare requirements worldwide.
Quick answers
Who was awarded contract SPE2DB25FZ1CN?
SPE2DB25FZ1CN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FZ1CN worth?
The government has obligated $14,122 on SPE2DB25FZ1CN.
Is contract SPE2DB25FZ1CN an order under another contract?
Yes. SPE2DB25FZ1CN is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FZ1CN competed?
The extent of competition for SPE2DB25FZ1CN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award